Az oldal megfelelő megjelenítéséhez engedélyezze böngészőjében a JavaScript használatát!

You are here

Képes Zita

Képes Zita

Name: Képes Zita

Other profiles: MTMT

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

49

Publications in DEA:

49

OA:

27

Date range:

2014-2024

2024

Barna, S., Sira, L., Bhattoa, H., Tóth, L., Czine, Z., Szoboszlay, L., Nagy, E., Képes, Z., Garai, I., Bodor, M., Varga, J., Nagy, E.: [<U+0091><U+0093><U+0091>I]6β-Iodomethyl-19-norcholesterol SPECT/CT for the Lateralization of Mineralocorticoid Overproduction in Primary Aldosteronism.
Diagnostics. 14 (17), 1-10, 2024.

Journal metrics:

Q2 Clinical Biochemistry (2023)
Képes, Z., Péli-Szabó, J., Kálmán-Szabó, I., Sass, T., Esze, R., Opposits, G., Jószai, I., Szikra, D., Fenyvesi, F., Hajdu, I., Trencsényi, G.: 52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: a Proof-of-concept Preclinical Study.
In Vivo. "Accepted by Publisher"2024.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q3 Cancer Research (2023)
Q2 Medicine (miscellaneous) (2023)
Q3 Pharmacology (2023)
Arató, V., Képes, Z., Péli-Szabó, J., Farkasinszky, G., Sass, T., Dénes, N., Kis, A., Opposits, G., Jószai, I., Kálmán, F., Hajdu, I., Trencsényi, G., Kertész, I.: Acute Myelomonoblastic Leukemia (My1/De): a Preclinical Rat Model.
In Vivo. 38 (3), 1064-1073, 2024.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q3 Cancer Research (2023)
Q2 Medicine (miscellaneous) (2023)
Q3 Pharmacology (2023)
Képes, Z., Hegedűs, É., Sass, T., Csikos, C., Péli-Szabó, J., Szugyiczki, V., Hajdu, I., Kertész, I., Opposits, G., Imrek, J., Balkay, L., Kálmán, F., Trencsényi, G.: Concomitant [18F]F-FAZA and [18F]F-FDG Imaging of Gynecological Cancer Xenografts: insight Into Tumor Hypoxia.
In Vivo. 38 (2), 574-586, 2024.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q3 Cancer Research (2023)
Q2 Medicine (miscellaneous) (2023)
Q3 Pharmacology (2023)
Esze, R., Barna, S., Fülöp, P., Kempler, P., Mikó, M., Páll, D., Paragh, G., Somodi, S., Emri, M., Képes, Z., Garai, I., Káplár, M.: C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity.
Diabetol Metab Syndr. 16 (1), 2024.

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism (2023)
Q1 Internal Medicine (2023)
Bunda, S., Kálmán-Szabó, I., Lihi, N., Képes, Z., Szikra, D., Péli-Szabó, J., Timári, I., Szűcs, D., May, N., Papp, G., Trencsényi, G., Kálmán, F.: Diagnosis of Melanoma with 61Cu-Labeled PET Tracer.
J. Med. Chem. [Epub ahead of print]2024.

Journal metrics:

D1 Drug Discovery (2023)
D1 Molecular Medicine (2023)
Esze, R., Balkay, L., Barna, S., Egeresi, L., Emri, M., Páll, D., Paragh, G., Rajnai, L., Somodi, S., Képes, Z., Garai, I., Káplár, M.: Impact of Fat Distribution and Metabolic Diseases on Cerebral Microcirculation: a Multimodal Study on Type 2 Diabetic and Obese Patients.
J Clin Med. 13 (10), 1-14, 2024.

Journal metrics:

Q1 Medicine (miscellaneous) (2023)
Káplár, M., Esze, R., Rajnai, L., Képes, Z., Balkay, L., Somodi, S., Paragh, G., Katkó, M., Emri, M., Garai, I., Fülöp, P.: Impact of liver fat content on serum levels of plasminogen activator inhibitor-1, fibroblast growth factor 21 and cerebral microcirculation in type 2 diabetes and obesity.
Képes, Z., Arató, V., Csikos, C., Hegedűs, É., Esze, R., Nagy, T., Jószai, I., Emri, M., Kertész, I., Trencsényi, G.: In Vivo Evaluation of Brain [18F]F-FDG Uptake Pattern Under Different Anaesthesia Protocols.
In Vivo. 38 (2), 587-597, 2024.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q3 Cancer Research (2023)
Q2 Medicine (miscellaneous) (2023)
Q3 Pharmacology (2023)
Farkasinszky, G., Péli-Szabó, J., Károlyi, P., Rácz, S., Dénes, N., Papp, T., Király, J., Szabó, Z., Kertész, I., Mező, G., Halmos, G., Képes, Z., Trencsényi, G.: In Vivo Imaging of Acute Hindlimb Ischaemia in Rat Model: a Pre-Clinical PET Study.
Pharmaceutics. 16 (4), 1-14, 2024.

Journal metrics:

Q1 Pharmaceutical Science (2023)
Trencsényi, G., Csikos, C., Képes, Z.: Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.
Int. J. Mol. Sci. 25 (1), 1-30, 2024.

Journal metrics:

Q2 Catalysis (2023)
Q1 Computer Science Applications (2023)
D1 Inorganic Chemistry (2023)
Q1 Medicine (miscellaneous) (2023)
Q2 Molecular Biology (2023)
D1 Organic Chemistry (2023)
Q1 Physical and Theoretical Chemistry (2023)
D1 Spectroscopy (2023)

2023

Csikos, C., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Gyuricza, B., Arató, V., Kárpáti, L., Mándity, I., Bruchertseifer, F., Halmos, G., Szikra, D., Trencsényi, G.: Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model.
Int. J. Pharm. 644 1-9, 2023.

Journal metrics:

Q1 Pharmaceutical Science
Képes, Z., Mikó, M., Kukuts, K., Esze, R., Barna, S., Somodi, S., Káplár, M., Varga, J., Garai, I.: Imaging with [99mTc]HMPAO - a novel perspective: investigation of [99mTc] HMPAO leg muscle uptake in metabolic diseases.
Acta Radiol. 64 (1), 187-194, 2023.

Journal metrics:

Q3 Medicine (miscellaneous)
Q3 Radiological and Ultrasound Technology
Q3 Radiology, Nuclear Medicine and Imaging
Polyák, A., Képes, Z., Trencsényi, G.: Implant Imaging: Perspectives of Nuclear Imaging in Implant, Biomaterial, and Stem Cell Research.
Bioengineering-Basel. 10 (5), 1-14, 2023.

Journal metrics:

Q3 Bioengineering
Képes, Z., Hajdu, I., Fenyvesi, F., Trencsényi, G.: Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: towards a novel oncological era.
Int. J. Pharm. 640 1-12, 2023.

Journal metrics:

Q1 Pharmaceutical Science
Szücs, D., Péli-Szabó, J., Arató, V., Gyuricza, B., Szikra, D., Tóth, I., Képes, Z., Trencsényi, G., Fekete, A.: Investigation of the Effect on the Albumin Binding Moiety for the Pharmacokinetic Properties of 68Ga-, 205/206Bi-, and 177Lu-Labeled NAPamide-Based Radiopharmaceuticals.
Pharmaceuticals (Basel). 16 (9), 1-17, 2023.

Journal metrics:

Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
Péli-Szabó, J., Csige, K., Kálmán-Szabó, I., Arató, V., Opposits, G., Jószai, I., Kertész, I., Képes, Z., Méhes, G., Fenyvesi, F., Hajdu, I., Trencsényi, G.: In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-[béta]-cyclodextrin (HPβCD) using positron emission tomography.
Int. J. Pharm. 630 1-8, 2023.

Journal metrics:

Q1 Pharmaceutical Science
Kálmán-Szabó, I., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Szücs, D., Gyuricza, B., Arató, V., Varga, J., Kárpáti, L., Garai, I., Mándity, I., Bruchertseifer, F., Elek, J., Szikra, D., Trencsényi, G.: In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
J. Pharm. Biomed. Anal. 229 1-9, 2023.

Journal metrics:

Q2 Analytical Chemistry
Q2 Clinical Biochemistry
Q2 Drug Discovery
Q2 Pharmaceutical Science
Q2 Spectroscopy
Trencsényi, G., Enyedi, K., Mező, G., Halmos, G., Képes, Z.: NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: a Preclinical Review.
Int. J. Mol. Sci. 24 (16), 1-34, 2023.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Képes, Z., Dénes, N., Kertész, I., Hajdu, I., Trencsényi, G.: Overview of Prostaglandin E2 (PGE2)-Targeting Radiolabelled Imaging Probes from Preclinical Perspective: Lessons Learned and Road Ahead.
Int. J. Mol. Sci. 24 (8), 1-15, 2023.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Trencsényi, G., Halmos, G., Képes, Z.: Radiolabeled NGR-Based Heterodimers for Angiogenesis Imaging: a Review of Preclinical Studies.
Cancers (Basel). 15 (18), 1-22, 2023.

Journal metrics:

Q2 Cancer Research
Q1 Oncology
Trencsényi, G., Képes, Z.: Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis.
Int. J. Mol. Sci. 24 (8), 1-23, 2023.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Képes, Z., Trencsényi, G.: Subrenal Capsule Assay - SRCA: The Promising Re-Emergence Of A Long-Forgotten Method in Preclinical Nuclear Medical Cancer Diagnostics.
J. Cancer. 14 (2), 183-192, 2023.

Journal metrics:

Q2 Oncology
Képes, Z., Arató, V., Péli-Szabó, J., Gyuricza, B., Szücs, D., Hajdu, I., Fekete, A., Bruchertseifer, F., Szikra, D., Trencsényi, G.: Therapeutic Performance Evaluation of 213Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([213Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: a Treasured Tailor for Oncology.
Pharmaceutics. 15 (2), 1-15, 2023.

Journal metrics:

Q1 Pharmaceutical Science
Aranyi, S., Képes, Z., Nagy, M., Opposits, G., Garai, I., Káplár, M., Emri, M.: Topological dissimilarities of hierarchical resting networks in type 2 diabetes mellitus and obesity.
J. Comput. Neurosci. 51 (1), 71-86, 2023.

Journal metrics:

Q4 Cellular and Molecular Neuroscience
Q4 Cognitive Neuroscience
Q4 Sensory Systems

Show all

updated: 2024-10-06, 01:20